1. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271–284
2. Ruiz-Esparza GU, Flores-Arredondo JH, Segura-Ibarra V, Torre-Amione G, Ferrari M, Blanco E, Serda RE (2013) The physiology of cardiovascular disease and innovative liposomal platforms for therapy. Int J Nanomedicine 8:629–640
3. Dvir T, Bauer M, Schroeder A, Tsui JH, Anderson DG, Langer R, Liao R, Kohane DS (2011) Nanoparticles for targeting the infarcted heart. Nano Lett 11:4411–4414
4. Hermanson GT (2013) Bioconjugate techniques, 3rd ed Chapter 21. Liposome conjugates and derivatives. Academic Press, pp 921–949
5. Torchilin VP, Weissig V (2003) Liposomes: practical approach, 2nd edn. Oxford University Press, Oxford